Interim CEO Michelle Brennan, who took over after CEO Joe Kiani resigned, will become the chair of Masimo’s board. A weekly newsletter by David Pierce designed to tell you everything you need to ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. The medtech has tapped Katie Szyman for the role, who has been serving as the worldwide ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board IRVINE ... track record of accelerating revenue growth by bringing new patient monitoring products to market, extensive experience ...

Interim CEO Michelle Brennan, who was backed by the activist investor, was appointed chairman of Masimo's board, and Politan founder Quentin Koffey was named the vice-chairman. The new ...

In late 2023, Apple received a small blow to its lucrative Christmas sales period thanks to the medical device manufacturer ...

Masimo (NASDAQ:MASI) is a global medical technology ... Nasdaq Stockholm Main Market (SEZI), with cross-trading on the New York OTCQX market (SNZZF). More information is available at senzime.com.

which resulted in a temporary injunction on the sale of some of the range towards the end of last year and subsequent removal of the blood oxygen measurement tech on new devices. Masimo sells a ...

Masimo's (NASDAQ:MASI) stock is up by a considerable 11% over the past three months. However, we wonder if the company's inconsistent financials would have any adverse impact on the current share ...